Clinical significance of skin autofluorescence in chronic kidney disease and diabetes

Clinical significance of skin autofluorescence in chronic kidney disease and diabetes - Skin autofluorescence in chronic kidney disease and diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012285

Enrollment

500

Registered

2013-11-13

Start date

2006-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic kidney disease and/or diabetes

Exclusion criteria

Exclusion criteria: Active malignancy; Pregnancy; Organ transplantation

Design outcomes

Primary

Measure	Time frame
Doubling of serum creatinine and/or need for dialysis	—

Secondary

Measure	Time frame
Total mortality; cardiavascular death; non-fatal cardiavascular event	—

Countries

Japan

Contacts

Public ContactKenichi Tanaka

Fukushima Medical University Department of Nephrology, Hypertension, Diabetology, Endcrinology, and Metabolism

im3@fmu.ac.jp024-547-1111

Outcome results